دورية أكاديمية

Prognostic Role of p53 Immunohistochemical Status in Invasive Breast Cancer. A Retrospective Review of 1387 Cases With Luminal-Like/Her2 Negative Breast Tumors.

التفاصيل البيبلوغرافية
العنوان: Prognostic Role of p53 Immunohistochemical Status in Invasive Breast Cancer. A Retrospective Review of 1387 Cases With Luminal-Like/Her2 Negative Breast Tumors.
المؤلفون: Dajti, Gerti, Serra, Margherita, Cisternino, Giovanni, Ceccarelli, Claudio, Pellegrini, Alice, Melina, Marica, Leo, Antonio De, Santini, Donatella, Taffurelli, Mario, Zanotti, Simone
المصدر: Oncologist; May2024, Vol. 29 Issue 5, p384-391, 8p
مصطلحات موضوعية: BREAST cancer prognosis, PROGESTERONE, IMMUNOPHENOTYPING, RESEARCH funding, BREAST tumors, RETROSPECTIVE studies, IMMUNOHISTOCHEMISTRY, GENE expression, PROGRESSION-free survival, CONFIDENCE intervals, GENETIC mutation
مستخلص: Purpose The aim of this study was to evaluate the prognostic role of p53 immunohistochemical (IHC) expression in a large cohort of patients with hormone receptors (HR)-positive/Her2-negative primary invasive breast cancer. Methods Retrospective review of consecutive cases treated at our Breast Unit between 2003 and 2013. Patients were divided into 3 subgroups based on p53 IHC expression: null (0%), low (0.1%-49%), and high (≥50%) p53 expression. Results A total of 1387 patients were included in the study with a median follow-up of 86 months. After adjusting for age, size, node status, lymphovascular invasion, progesterone, and Ki67 expression, only null p53 immunophenotype was associated with worse disease-free survival (DFS) (OR 1.74, 95% IC, 1.11-2.71, P  = .015) and distant recurrence-free survival (DRFS) (OR 1.73, 95% IC, 1.04-2.90, P  = .036). Null p53 impacted significantly DFS and DRFS also in patients with early breast cancer. Conclusions p53 IHC expression affects survival and, thus can be a valuable tool in the management of patients with HR-positive/Her2-negative breast cancer [ABSTRACT FROM AUTHOR]
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:10837159
DOI:10.1093/oncolo/oyad309